SCIENTIFIC COMMITTEE
N. Ciavarella
ITALY
Former Director of the Hemophilia and Thrombosis Center of the Bari University Hospital. Coordinator of the Technical Panel on Thrombosis of the Apulia Region, Bari, Italy
A. B. Federici
ITALY
Associate Professor of Hematology at the Department of Internal Medicine, University of Milan and Head of Hematology and Transfusion Medicine at the University Hospital L. Sacco of Milan, Italy
F. Peyvandi
ITALY
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
P. M. Mannucci
ITALY
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
SPEAKERS
L. M. Aledort
USA
Professor of Medicine, Hematology and Medical Oncology - Icahn Mount Sinai School of Medicine - New York, USA
Title:"The challenges of innovative therapeutic interventions in hemophilia"
M. Carcao
CANADA
Associate Professor – Hospital for Sick Children, Hemophilia Clinic, Toronto (ON), Canada.
Preliminary
Title: "Will severe hemophilia become more common in future? The
effects of populations demographics on the incidence of hemophilia
G. Castaman
ITALY
Director of Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy
P. Coppo
FRANCE
French reference Center for Thrombotic Microangiopathies; Professor of Haematology at Saint-Antoine Hospital, Paris, France. Preliminary title: "Acquired TTP: are we ready for a prognosis-dependent management?"
M. Cugno
ITALY
Department of medical, surgical and transplant physiopathology of the
University of Milan, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore
Policlinico, University of Milan, Milan, Italy.
Preliminary title: "Treatment monitoring in the atypical hemolytic uremic syndrome (HUS)"
S. De Meyer
BELGIUM
Associate Professor at the Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium
Preliminary title: "Von Willebrand factor in ischemic stroke"
C. Denis
FRANCE
Institut National de la Santé et de la Recherche Médicale (INSERM) U1176, Le Kremlin-Bicetre, France.
Preliminary title: "The many faces of thrombocytopenia in von Willebrand disease type 2B"
G. Di Minno
ITALY
Department of Clinical and Experimental Medicine, University of Naples Federico II, Naples, Italy
Title:"Predictors of outcome in ITI: the Italian Registry"
V. Flood
USA
Children's Hospital of Wisconsin-Milwaukee Campus, Milwaukee, USA.
Preliminary title: "Collagen and VWF interactions and beyond."
M. Franchini
ITALY
Servizio di immunoematologia e trasfusione, Azienda Ospedaliera Carlo Poma, Mantova, Italy
A. C. Goodeve
UK
Head of Sheffield Haemostasis Research Group – Department of
Infection, Immunity & Cardiovascular Disease – Faculty of Medicine,
Dentistry and Health – University of Sheffield, Sheffield, UK.
Preliminary title: "The genetics of von Willebrand disease: recent developments."
J. A. Kremer Hovinga
SWITZERLAND
Head of the Hemostasis Research Laboratory at Berne University Hospital, Bern, Switzerland
S. Lacroix-Desmazes
FRANCE
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Centre de Recherche des Cordeliers Paris, France
Preliminary title: "Endocytosis of factor FVIII by antigen-presenting cells: roles of von Willebrand factor and complement"
J. C. Laurence
USA
Professor of Medicine, Weill Cornell Medical College, and Attending
Physician, New York Presbyterian Hospital-Cornell, New York, USA
Preliminary title: "Differential diagnosis of thrombotic microangiopathies"
P. J. Lenting
FRANCE
Inserm U770, Le Kremlin-Bicêtre, France.
Preliminary title: "The potential use of nanobodies in the treatment of VWD and hemophilia."
D. Lillicrap
CANADA
Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen’s University, Kingston (ON), Canada.
Preliminary title: "Determinants of FVIII inhibitor risk: Is VWF a key factor?"
J. A. López
USA
Bloodworks Northwest Research Institute – Professor of Medicine, Division of Hematology – University of Washington – School of Medicine, Seattle, USA
M. Makris
UK
Professor of Haemostasis and Thrombosis at University of Sheffield and Director of the Sheffield Haemophilia and Thrombosis Centre, Sheffield, UK
D. Meyer
FRANCE
Professeur émérite d'hématologie, Université Paris XI, Académie des sciences, Paris, France
F. Mingozzi
FRANCE
Associate Professor, University Pierre and Marie Curie, Paris, Team Leader, Genethon, Evry, France
Prelimiary Title: "Addressing vector immunogenicity in the development of AAV-based gene therapies for bleeding disorders"
R. R. Montgomery
USA
Pediatric hematologist at the Blood Research Institute in Milwaukee, USA
L. Naldini
ITALY
Director of the San Raffaele Telethon Institute for Gene Therapy and Professor at the San Raffaele University, Milan, Italy
Title: "Liver-directed lentiviral gene therapy of hemophilia".
A. Nathwani
UK
Research Department of Haematology, Cancer Institute, Faculty of Medical Sciences, London, UK
Preliminary title: "An update on UCL/St Jude Haemophilia studies; successes and obstacles ahead".
M. Noris
ITALY
Laboratory of Immunology and Genetics of Rare Diseases – IRCCS-Mario Negri Institute for Pharmacological Research – Ranica (BG), Italy
J. Oldenburg
GERMANY
Chairman and Director of the University Clinic Bonn Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany
A. M. Randi
UK
Professor of Cardiovascular Medicine – Imperial Centre for
Translational and Experimental Medicine – Imperial College London NHLI
Vascular Sciences – Hammersmith Hospital – London, UK.
Preliminary title: "VWF regulation of blood vessel formation and function."
G. Remuzzi
ITALY
Professor of Nephrology, Mario Negri Institute for Pharmacological Research – Centro Anna Maria Astori – Science and Technology Park “Kilometro Rosso”, Bergamo, Italy. Preliminary title: "The most recent advances in aHUS and TTP including complement and VWF-complement interactions."
F. R. Rosendaal
THE NETHERLANDS
Professor of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
Title: "Randomisation or real world data?"
Z. M. Ruggeri
USA
Department of Molecular and Experimental Medicine, Scripps Clinic, La Jolla (CA), USA.
Preliminary title: "Old concepts and new functions of von Willebrand factor: 2017."
M. Shima
JAPAN
Department of Pediatrics, Nara Medical University – Nara, Japan
Preliminary Title: "Paradigm shift of the treatment of hemophilia A by FVIII mimicking bispecific antibody"
K. Vanhoorelbeke
BELGIUM
Faculty of Science, Campus Kulak Kortrijk, KU Leuven Kortrijk, Belgium.
Preliminary title: "Emerging concepts in acquired thrombotic thrombocytopenic purpura."
J. Voorberg
THE NETHERLANDS
Department of Plasma Proteins – Sanquin Research and University of Amsterdam, Amsterdam, the Netherlands
Preliminary Title: "Immune recognition of ADAMTS13 in acquired TTP"
D. Wagner
USA
Edwin Cohn Professor of Pediatrics
Center for Blood Research
Professor of Pediatrics, Program in Cellular and Molecular Medicine and
Div. of Hematology / Oncology. Boston Children's Hospital. Harvard
Medical School, Boston, USA.
Preliminary Title: "Interplay between VWF/ADAMTS13 and NETs"
W. Y. Wong
USA
BioMarin, USA
X. L. Zheng
USA
Robert B. Adams Endowed Professor and Director, Laboratory Medicine -
Interim Director, Informatics - Department of Pathology UAB, the
University of Alabama at Birmingham, AL, USA
Preliminary title: "Mechanism of thrombotic microangiopathy: lesson from zebrafish to men"